Simultaneously detect and quantify many biomarkers from the same sample.
An innovative, rapid and multiplexed analysis platform that supports a broad range of biological assays; its open architecture allows customization for the user's specific needs.
Multiplex Detection Platform
Automate skin care.
Vibrating and rotating brush cleanses and exfoliates skin more effectively than hand-cleansing, can be used in the shower, and can be recharged for up to 15 days of use.
Facial Cleaning Brush
Extract RNA and DNA from different specimens in a single run.
A flexible, automated benchtop system that quickly processes multiple samples and features an easy-to-use design and intuitive touch-screen.
bioMérieux NucliSens easyMAG
Nucleic Acid Extraction System
Diagnose dry eye syndrome.
Fast-turnaround initial indicator using a small sample of tear fluid and limited space.
TearLab Osmolarity System
In-vitro Diagnostic Tear Testing Platform
Analyze blood samples in less than five minutes.
Portable instrument that requires limited space, enables multiple testing from a single sample, protects the user from exposure to blood and connects to hospital information systems.
Critical Care Diagnostics
Provide accurate diagnosis up to 50% faster.
Fully automated robotic system that reduces run times, requires less reagent and produces less hazardous waste.
Leica Microsystems Bond-III
Automated IHC & ISH Staining System
Invetech and Argos Therapeutics Announce Agreement To Support Global Production of Fully Personalized Immunotherapies
Anthony Annibale appointed to lead Invetech's Consumer and Industrial Products division
Invetech & Janssen Research & Development announced as 2014 BioProcess International Awards finalists
Highlights from Invetech at AACC 2014
Invetech innovation workshop at IBC Cell Therapy Bioprocessing conference
Dover Joins Invetech
Invetech and Biocartis Announce Collaboration Agreement For Production of Multiplex Biomarker Analysis Platform Evalution™
Senior program manager Jurg Bartholdi joins Invetech San Diego
Invetech team to attend the Molecular Med TRI-CON 2014 conference, San Francisco
Invetech's Bob Speziale reports from Phacilitate Cell and Gene Therapy Forum 2014